G RENOBLE, France - July 1 st - CEA-Leti, a technology research institute of CEA, today announced that Sebastien Dauvé has been named CEO, succeeding Emmanuel Sabonnadiere. Sebastien Dauvé was named Director of CEA-Leti effective on July 1, 2021, after more than twenty years of experience in microelectronics technologies and their applications, including clean mobility, medicine of the future, and cybersecurity.
The 500°C threshold is key in 3D sequential technologies because processing the upper-level transistors at temperatures higher than that can damage the metal interconnects and the silicide of the bottom-level transistors.
"The shortcomings of current tests have serious consequences in terms of public health, with several billion incidents of food poisoning annually, and in terms of waste of many tons of food because of contamination, not to mention the financial-and-image consequences for food processors," said Thomas Bordy, a co-founder of Direct Analysis.
GRENOBLE, France - July 1 st - CEA-Leti, a technology research institute of CEA, today announced that Sebastien Dauvé has been named CEO, succeeding Emmanuel Sabonnadiere.
MmWave systems operate in frequency ranges from 30 to 300 GHz. CEA-Leti's previous work in mmWave communications includes design and use of 5G networks on the MINATEC campus in Grenoble. In addition to being the next challenge to delivering the full potential of 5G, mmWave technology will be required for future innovative services such as fixed, super-high-speed broadband access, industrial automation, healthcare and intelligent transport systems.
Targeted Applications Include High-Dimensional Distributed Environmental Monitoring, Implantable Medical-Diagnostic Microchips, Wearable Electronics & Human/Computer Interfaces GRENOBLE, France - April 20, 2021 - CEA-Leti announced today the launch of an EU project to develop a novel class of algorithms, devices and circuits that reproduce multi-timescale processing of biological neural systems.
Slowing the progression of Parkinson's disease through neuroillumination: first patient implant in first clinical trial -The CEA, Grenoble Alpes University Hospital, Grenoble Alpes University and Boston Scientific Corporation, a leading company in medical devices, have started on the Near Infra Red (NIR) project clinical trial in March 2021.